Desferrioxamine
ATC — · 3 markets · 14 records
Desferrioxamine
Forms
GB 11 records · 3 strengths
- 2,000 mginjectionDesferal 500mg powder for solution for injection vials__no_trade__
- 500 mginjectionDesferal 500mg powder for solution for injection vials__no_trade__
Records without a stated strength · 1 __no_trade__
AU 2 records · 2 strengths
- 2,000 mginjectionDBL Desferrioxamine Mesilate
- 500 mginjectionDBL Desferrioxamine Mesilate
SG 1 records · 1 strengths
- 500 mg/vialinjectionDBL DESFERRIOXAMINE MESYLATE FOR INJECTION BP 500 mg/vial
| Strength / form / release | GB | AU | SG |
|---|---|---|---|
| 2,000 mgRecorded as: 2 g injection | No trade name Desferal 500mg powder for solution for injection vials | DBL Desferrioxamine Mesilate | |
| 500 mg injection | No trade name Desferal 500mg powder for solution for injection vials | DBL Desferrioxamine Mesilate | |
| 500 mg/vial injection | DBL DESFERRIOXAMINE MESYLATE FOR INJECTION BP 500 mg/vial | ||
liquid | No trade name |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.